Skin Cancer Stage III
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis (NCT04305145) | Massachusetts General Hospital | 2020-08-31 |
Track Skin Cancer Stage III automatically
Every clearance here is in the API, with alerts when new ones post.